Linfohistiocitosis hemofagocítica

##plugins.themes.bootstrap3.article.main##

Jhon Ferney Cerquera Rojas Universidad Surcolombiana, Hospital Universitario de Neiva, Neiva, Colombia
Liliana del Pilar Lozano Macías Universidad Surcolombiana, Neiva, Colombia
Doris Martha Cecilia Salgado Universidad Surcolombiana, Neiva, Colombia.
Resumen
El síndrome hemofagocítico, considerado como una entidad poco frecuente, de etiología multifactorial, y cuya presentación es la de un cuadro grave y de alta letalidad, ofrece dificultades en la aproximación diagnostica temprana. Se presenta el caso de un niño de 26 meses de edad, con síndrome febril prolongado asociado a pancitopenia y visceromegalias (hepatoesplenomegalia) rápidamente crecientes en el curso de la evolución. Durante la hospitalización requiere varias transfusiones de hemoderivados sin mejoría. Se descartan enfermedades infecciosas como toxoplasmosis, citomegalovirus, SIDA, hepatitis B y sífilis, al igual que etiología linfo y mieloproliferativa. Se usan herramientas de laboratorio que orientan el diagnóstico a linfohistiocitosis hemofagocitica secundaría a infección por Virus Epstein-Barr, y recibe tratamiento con Inmunoglobulina y esteroides con evolución satisfactoria. Es importante considerar dentro de las causas de síndrome febril prolongado, patologías como la linfohistiocitosis hemofagocítica, secundaria a agentes comunes en nuestro medio como el Epstein Barr virus.
Palabras clave

Descargas

Los datos de descargas todavía no están disponibles.

##plugins.themes.bootstrap3.article.details##

Biografía del autor/a / Ver

Jhon Ferney Cerquera Rojas, Universidad Surcolombiana, Hospital Universitario de Neiva, Neiva, Colombia

Residente de Pediatría.

Liliana del Pilar Lozano Macías, Universidad Surcolombiana, Neiva, Colombia

Pediatra, Hospital Universitario de Neiva. Docente Medicina, Universidad Surcolombiana, Neiva, Colombia.

Doris Martha Cecilia Salgado, Universidad Surcolombiana, Neiva, Colombia.

Director Servicio Infectología, Hospital Universitario de Neiva. Docente Medicina, Universidad Surcolombiana, Neiva, Colombia.
Referencias

Sumit Gupta and Sheila Weitzman. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol 2010;6(1):137-154.

Henter JI, Elinder G, Soder O, Ost A. Incidence in Sweden and clinical eatures of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 1991;80:428-435.

Filipovich A. Hemophagocytic lymphohistiocytosis. Immunol Allergy Clin N Am 2002; 22:281-300.

Schneider EM, Lorenz I, Müller-Rosenberger M, Steinbach G, Kron M, Janka-Schaub GE. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood 2002;100(8):2891-2898.

Gritta E. Janka. Hemophagocytic sindromes. Blood Reviews, Elsevier 2007;21:245-253.

Schneider EM, Lorenz I, Muller-Rosenberger M, Steinbach G, Kron M, Janka-Schaub GE. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cellinduced apoptosis. Blood 2002;100:2891-2898.

Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 2004;104:735-743.

Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983;140:221-230.

Clementi R, Emmi L, Maccario R, et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood 2002;100:2266-2267.

Risdall RJ, McKenna RW, Nesbit ME, et al. Virusassociated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979;44:993-1002.

Janka G, Imashuku S, Elinder G, Schneider M. Henter JI. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12:435-444.

Gagnaire MH, Galambrun C, Stephan JL. Hemophagocytic syndrome: A misleading complication of visceral leishmaniasis in children-a series of 12 cases. Pediatrics 2000;106:E58.

Janka G. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr 2007; 166(2):95-109.

Henter JI, Ehrnst A, Andersson J, Elinder G. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr 1993;82:369-372.

Falini B, Pileri S, De Solas I, et al. Peripheral Tcell lymphoma associated with hemophagocytic syndrome. Blood 1990;75:434-444.

Takahashi N, Chubachi A, Miura I, Nakamura S, Miura AB. Lymphoma-associated hemophagocytic syndrome in Japan. Rinsho Ketsueki 1999;40:542-549.

Kaito K, Kobayashi M, Katayama T, et al. Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol 1997;59:247-253.

Takahashi N, Chubachi A, Kume M, et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 2001;74:209-213.

Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 1985;106:561-566.

Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002;14:548-552.

Ramanan A, Laxer R, Schneider R. Secondary hemophagocytic syndromes associated with rheumatic diseases. In: Weitzman S, Egeler RM, editors. Histiocytic disorders of children and adults. Cambridge: Cambridge University Press 2005;380-395.

Janka GE. Familial erythrophagocytic lymphohistiocytosis. Eur J Pediatr 1983;140:221-230.

Arico M, Janka G, Fischer A et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. Leukemia 1996;10:197-203.

Hirst WJ, Layton DM, Singh S, Mieli-Vergani G, Chessells JM. Haemophagocytic lymphohistiocytosis: experience at two U.K. centres. Br J Haematol 1994;88:731-739.

Morrell DS, Pepping MA, Scott P, Esterly NB, Drolet BA. Cutaneous manifestations of hemophagocytic lymphohistiocytosis. Arch Dermatol 2002;138:1208-1212.

Horne A, Trottestam H, Arico M et al. Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis. Br J Haematol 2007;140:327-335.

Stapp J, Wilkerson S, Stewart D et al. Fulminant neonatal liver failure in siblings: probably congenital hemophagocytic lymphohistiocytosis. Pediatr Dev Pathol 2006;9(3):239-244.

Gupta A, Tyrrell P, Valani R et al. The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2008;51:402-404.

Schneider EM, Lorenz I, Walther P, Janka GE. Natural killer deficiency: a minor or major factor in the manifestation of hemophagocytic lymphohistiocytosis? J Pediatr Hematol Oncol 2003;25(9):680-683.

Janka G, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 2004;124:4-14.

Henter JI, Horne A, Arico M et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 2007;48:124-131.

Henter JI. Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis. Med Pediatr Oncol 2002;38:305-309.

Maakaroun NR, Moanna A, Jacob JT, and Albrecht H. Viral infections associated with haemophagocytic sindrome. Rev Med Virol 2010;20:93-105.

Sistema OJS - Metabiblioteca |